Synedgen Announces Distribution Agreement with Europharma Concepts

Share Article

Synedgen Inc. and Europharma Concepts Ltd. announce joint license, supply, and distribution agreement to develop and market oral care products based on Synedgen’s proprietary SYN01 technology.

Synedgen Inc. and Europharma Concepts Ltd. are pleased to announce that they have entered into a joint license, supply, and distribution agreement to develop and market oral care products based on Synedgen’s proprietary SYN01 technology.

The companies will first launch an oral rinse in Scandinavia, with follow up distribution in Western Europe. The oral rinse contains a unique, new formulation that gently removes plaque while maintaining a natural oral flora and healthy mouth. Unlike other oral rinse products that contain harsh or environmentally unfriendly chemicals such as alcohol, chlorhexidine, and triclosan, this new product relies on a patented combination of natural-based products that do not damage oral tissue and have no consequence in the environment.

Compared to other brands, Synedgen and Europharma’s oral rinse shows improved efficacy in removing and preventing the build-up of plaque on teeth and gums. It is mouth-friendly, with a neutral pH and fresh taste that doesn’t harm normal or damaged tissue, and will not leave any residual stain on teeth.

The product launch is anticipated for the summer of 2012. “Europharma is an experienced world leader in the production, marketing and distribution of oral care products internationally. We are pleased to work with the knowledgeable team at Europharma and to introduce this and other oral care products based on the Synedgen technology into the marketplace,” said Synedgen President Shenda Baker.

Europharma CEO Declan Lenahan also welcomed the agreement. “The SYN01 oral rinse represents a new era in oral care. This new technology fills an unmet niche in oral health care by providing a safe, highly effective, pleasant tasting oral regimen. Europharma Concepts are very excited about bringing this unique, advanced and safe technology to the oral care market.”

About Synedgen
Synedgen Inc. is an innovative biopharmaceutical company focused on developing novel therapies and products through its proprietary biomaterials technology platform. This platform technology provides the foundation for preventing bacterial growth and disruption of biofilms in human and environmental applications. Product development is targeted to specifically address unmet needs for therapies that treat and prevent infections, primarily from bacteria that have developed resistance to traditional antibiotics.

Synedgen’s Corporate Headquarters and Research Laboratories are in Claremont CA; Synedgen’s Manufacturing Facility is in Honolulu HI. Additional information can be found at Synedgen’s web site at

About Europharma Concepts
Europharma Concepts is the world leader in the development and manufacture of oral care products. Europharma Concepts has to date developed and supplied a large number of oral care formulations to the European market place. In 2011, the Irish Exporters Association honored Europharma with the Life Sciences Exporter of the year award.

Europharma is headquartered in Clara, Co. Offaly, Ireland. Additional information can be found at Europharma’s web site at

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Nicole Draghic
Synedgen Inc
(301) 428-9818 x250
Email >
Visit website